Nuveen Asset Management’s Precision BioSciences DTIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-17,010
| Closed | -$1.56M | – | 3281 |
|
|
2022
Q1 | $1.56M | Buy |
17,010
+1,179
| +7% | +$108K | ﹤0.01% | 2629 |
|
|
2021
Q4 | $3.52M | Buy |
15,831
+483
| +3% | +$107K | ﹤0.01% | 2293 |
|
|
2021
Q3 | $5.31M | Buy |
15,348
+9,865
| +180% | +$3.42M | ﹤0.01% | 2175 |
|
|
2021
Q2 | $2.06M | Sell |
5,483
-356
| -6% | -$134K | ﹤0.01% | 2696 |
|
|
2021
Q1 | $1.81M | Buy |
5,839
+730
| +14% | +$227K | ﹤0.01% | 2663 |
|
|
2020
Q4 | $1.28M | Sell |
5,109
-1,727
| -25% | -$432K | ﹤0.01% | 2717 |
|
|
2020
Q3 | $1.26M | Buy |
6,836
+28
| +0.4% | +$5.17K | ﹤0.01% | 2587 |
|
|
2020
Q2 | $1.7M | Buy |
6,808
+633
| +10% | +$158K | ﹤0.01% | 2407 |
|
|
2020
Q1 | $1.12M | Buy |
6,175
+1,222
| +25% | +$221K | ﹤0.01% | 2470 |
|
|
2019
Q4 | $2.06M | Buy |
4,953
+4,500
| +993% | +$1.88M | ﹤0.01% | 2408 |
|
|
2019
Q3 | $114K | Hold |
453
| – | – | ﹤0.01% | 3158 |
|
|
2019
Q2 | $180K | Buy |
+453
| New | +$180K | ﹤0.01% | 3173 |
|